Document is current
Any future updates will be listed below
-
Authors
Wu, Caixia
Li, Xianjie
Yang, Xiaoya
Wang, Han
Lin, Guanzhen
Liu, Zhaoming
-
Funding
Funding for this research was provided by:
the GDAS Project of Science and Technology Development (2023GDASZH-2023030602)
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 19 November 2025
First Online: 12 December 2025
Declarations
:
: (1) Animal ethics declaration:All animal experiments were conducted in compliance with the ARRIVE guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) of [Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences] for the project ' Establishment of autism models in SD rats and C57 mice and stem cell therapy ' (IACUC: No. 2023081). Final approval was granted on [November 20, 2023]. (2) Statement of life sciences and medical ethics: Human sample collection was approved by the [Ethics Committee of Hunan Provincial Maternal and Child Health Hospital] (Approval No. 202120) for the project [Preclinical Research on Stem Cell Therapy for Diabetes in Children] on [27 April 2021]. Written informed consent was obtained from all participants/guardians. All procedures followed the guidelines of the National Health and Medical Research Council of China and received approval(GIBH-LMEC2024-091-01(AL)) from the Committee on Life Sciences and Medical Ethics of Guangzhou Institutes of Biomedicine and Health, CAS for the project [Research on the Mechanism of stem Cell Therapy in the mouse Autism Model Induced by VPA] on [August 15, 2024].
: The authors declare no competing interests.
